Entia Biosciences, Inc (OTCPK:ERGO) announced that it will receive $400,000 in funding on April 23, 2015. The company will issue common stock and option, warrant or other right to acquire another security in the transaction. The minimum investment accepted from any outside investor is $10,000.

The company will issue securities pursuant to exemption provided under Regulation D. The transaction is to be carried by the management.